Usen Todd 4
4 · Adagio Medical Holdings, Inc. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Adagio Medical (ADGM) CEO Usen Todd Receives 800,000-Share Option Award
What Happened
Usen Todd, CEO of Adagio Medical Holdings, Inc. (ADGM), was granted a derivative award on March 6, 2026: an option covering 800,000 shares. The Form 4 reports the acquisition at $0.00 (standard for grants/awards on the form); this is a stock option award (see footnote). No cash changed hands in this reporting entry.
Key Details
- Transaction date: 2026-03-06 (reported on Form 4 filed 2026-03-09).
- Instrument and amount: Option award for 800,000 shares (derivative), reported at $0.00.
- Vesting: 25% vests on March 6, 2027; remaining shares vest in 36 equal monthly installments thereafter (four-year total vesting). (Footnote F1)
- Shares owned after transaction: Not specified in the filing.
- Timeliness: Filing appears timely (filed three days after the grant; within standard Section 16 reporting window).
- Other: This is a grant under the Issuer’s 2024 Equity Incentive Plan.
Context
This filing documents a typical executive option grant that vests over time and does not represent an immediate market purchase or sale. Such awards are common as long-term incentive compensation; they only translate into tradable shares if and when options are exercised and vested. The Form 4 entry itself does not indicate an immediate cash investment or sale by the insider.
Insider Transaction Report
- Award
Employee Stock Options (Right to Buy)
[F1]2026-03-06+800,000→ 800,000 totalExercise: $0.98Exp: 2036-03-06→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]Employee Stock Options granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest over a four-year period, whereby twenty-five percent (25%) of the Option will vest on March 6, 2027, with the remaining shares subject to the Option vesting in thirty-six (36) equal monthly installments thereafter.